NOX 14.3% 8.0¢ noxopharm limited

Impact of COVID-19 on clinical trials, page-3

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    so the Nepal journal of epidemiology.….published 12 months ago.
    Right. It’s certainly true pandemic disrupted non Covid treatment clinical trials especially early on in pandemic but the impact not equal everywhere and Australia by and large has managed to keep running trials quite well. If I assume posting this paper is an attempt to excuse the lack of trial progress in iconic trial 6 months after ethics approval would I be pretty warm?
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.010(14.3%)
Mkt cap ! $23.37M
Open High Low Value Volume
7.0¢ 8.0¢ 7.0¢ $4.207K 56.02K

Buyers (Bids)

No. Vol. Price($)
1 118527 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.